View Older Stories
-
Brown Forman (BF-B) PT Raised to $32 at Evercore ISI
-
CFRA Downgrades Brown Forman (BF-B) to Sell
-
RBC Capital Reiterates Sector Perform Rating on Brown Forman (BF-B)
-
JPMorgan Assumes Brown Forman (BF-B) at Underweight
-
TD Cowen Reiterates Hold Rating on Brown Forman (BF-B) as '1Q US Spirits Depletions Remain Weak'
-
Brown Forman (BF-B) PT Lowered to $32 at UBS as Visibility Is Limited
-
Berenberg Reiterates Hold Rating on Brown Forman (BF-B)
-
RBC Capital Reiterates Sector Perform Rating on Brown Forman (BF-B)
-
Brown Forman (BF-B) PT Raised to $33 at UBS
-
Brown Forman (BF-B) PT Raised to $33 at Barclays
-
Redburn-Atlantic Upgrades Brown Forman (BF-B) to Neutral
-
Brown Forman (BF-B) PT Lowered to $30 at UBS
-
Brown Forman (BF-B) PT Lowered at Bernstein Following 'Painful' Results
-
Bernstein on Brown Forman (BF-B): 'The Print is Painful'
-
Brown Forman (BF-B) PT Lowered to $30 at RBC Capital
-
Brown Forman (BF-B) PT Lowered to $28 at Citi
-
Brown Forman (BF-B) PT Lowered to $30 at Evercore ISI
-
Brown-Forman (BF-A) Misses Q1 EPS by 3c
-
Brown Forman (BF-B) PT Lowered to $53 at Bernstein Amid 'Trump Storm'
-
Citi Reiterates Neutral Rating on Brown Forman (BF-B)
-
Brown-Forman (BF-A) Announces Significant Evolution in U.S. Distribution
-
Berenberg Starts Brown Forman (BF-B) at Hold
-
Bernstein: 'What Is Driving US Alcohol Weakness, and Why It Matters'
-
Jack Daniels maker caught in middle of escalating EU/U.S. trade war
-
Brown Forman (BF-B) PT Raised to $39 at UBS
-
TD Cowen Reiterates Hold Rating on Brown Forman (BF-B) as 'Tariff Uncertainty Looms'
-
Brown Forman (BF-B) PT Lowered to $40 at Truist Securities
-
Brown Forman (BF-B) PT Lowered to $40 at Evercore ISI
-
Morgan Stanley Downgrades Brown Forman (BF-B) to Underweight
-
Brown Forman (BF-B) PT Lowered to $38 at Goldman Sachs
-
Brown Forman (BF-B) PT Lowered to $44 at RBC Capital Amid 'Near-Term Pressures'
-
Brown Forman (BF-B) PT Lowered to $38 at TD Cowen as 'Leadership Changes & Workforce Reduction Signal Extended Slowdown'
-
Bernstein covers Brown Forman's (BF-B) "Strategic Initiatives for Growth": 'BF Faces a Long Road Ahead'
-
Brown-Forman (BF-A) Announces Strategic Initiatives for Growth
-
Brown Forman (BF-B) PT Lowered to $57.50 at Bernstein SocGen Group, Reflecting Updated Forecast
-
JPMorgan Downgrades Brown Forman (BF-B) to Underweight
-
Truist Securities Downgrades Brown Forman (BF-B) to Hold
-
Bernstein on Brown Forman (BF-B) Post Q2 F25 Results: 'An early Christmas present?'
-
Brown-Forman (BF-B) proactively preparing for potential tariffs - Bloomberg
-
Morgan Stanley Reiterates Equalweight Rating on Brown Forman (BF-B)
-
Truist Securities Reiterates Buy Rating on Brown Forman (BF-B)
-
Goldman Sachs Reiterates Sell Rating on Brown Forman (BF-B)
-
RBC Capital Reiterates Sector Perform Rating on Brown Forman (BF-B) as 'Challenges Still Persist'
-
Brown Forman (BF-B) PT Lowered to $49 at Barclays
-
TD Cowen Upgrades Brown Forman (BF-B) to Hold
-
Brown Forman (BF-B) PT Lowered to $66 at Bernstein SocGen Group
-
Truist Securities Reiterates Buy Rating on Brown Forman (BF-B)
-
Brown-Forman (BF-B) Misses Q1 EPS by 4c, Offers Guidance
-
TD Cowen Reiterates Buy Rating on Brown Forman (BF-B)
-
Citi Reiterates Neutral Rating on Brown Forman (BF-B)

